FdaApplication
ANDA 210955
Identifiers
- fda_app_no: ANDA210955
Properties
| Property | Value |
|---|---|
| applicant_name | REGCON HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2018-07-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NADOLOL | NADOLOL | 20MG | TABLET;ORAL |
| NADOLOL | NADOLOL | 40MG | TABLET;ORAL |
| NADOLOL | NADOLOL | 80MG | TABLET;ORAL |
3 products